Thursday, December 29 2016
Today's Research Daily features new research reports on 16 major stocks, including Wells Fargo (WFC), Danaher (DHR) and Colgate-Palmolive (CL).
Shares of Buy rated Wells Fargo have gained 1.8% year to date, underperforming the Zacks Banks - Major Regional sector which has gained 21.4% over the same period. Wells Fargo has long maintained a reputation for disciplined and reliable operations and an attractive retail banking franchise. Regrettably, the sales practices controversy has taken center stage and cost the well regarded CEO his position.
However, the new management team is making all the right moves and further downside risks in the stock are low at this stage. Though it will likely take a while for clouds to fully lifted, continued growth in loans and deposits and expansion moves should support its growth profile (You can read the full research report on Wells Fargo here.)
Danaher shares have declined 15.9% year to date, underperforming the Zacks Diversified Operations sector, which has gained 7.8% over the same period. Its shares have struggled lately on concerns about its business repositioning that involved greater exposure to the healthcare and environmental verticals following the Fortive spin-off. The analyst points out that the new Danaher is less exposed to volatile end-markets following the spin-off and has a more recurring revenue business.
On the flip side, sluggish economic conditions across some key operating regions and unfavorable currency translations pose as significant headwinds. (You can read the full research report on Danaher here.)
Colgate-Palmolive shares have slipped 1.5% year to date, underperforming the Zacks Soap and Cleaning Materials sector, which has gained 1.4% over the same period. The analyst likes its product innovation, globally recognized brands and presence in both developed and emerging economies. The company anticipates delivering robust organic sales growth, backed by new products across categories and geographical regions.
However, as the company derives 75% of its revenues from operations outside the U.S., it expects macroeconomic headwinds and currency woes to linger and weigh on its top and bottom lines in 2016. (You can read the full research report on Colgate-Palmolive here.)
Other noteworthy reports we are featuring today include Zoetis (ZTS), STERIS (STE) and Aetna (AET).
Today's Private Buys & Sells from Zacks Research
While we share the above news with the public, our sensitive recommendations are hidden from everyone but selected members. Would you like to peek behind the curtain and view them?
Starting today, for the next month, you can follow all Zacks' private buys and sells in real time from value to momentum . . . from stocks under $10 to ETF and option moves . . . from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for Zacks' secret trades >>
Note: If you want an email notification each time Zacks Director of Research Sheraz Mian publishes a new article, please click here>>>
Today's Must Read
Wells Fargo (WFC) Exhibits Organic Growth; Raises Prime Rate
Danaher (DHR) Hit by Academic & Industrial Market Weaknesses
Colgate's (CL) Strategies on Track, Currency Woes Persist
Foot Locker's (FL) Strategic Endeavors Bode Well
The Zacks analyst thinks strategic efforts like cost containment, shop-in-shop expansion, store refurbishment and merchandise enhancement help it sustain in a competitive retail landscape.
Oil Volatility Clouds National Oilwell Varco (NOV) Outlook
While NOV's cost reduction efforts and large installed base of rigs bode well, the covering analyst would prefer to wait for further oil price recovery before recommending investors purchase shares.
O'Reilly (ORLY) Set to Grow Despite Geographic Concentration
While strong distribution network, dual-market strategy, rapid store expansion and active share repurchase are growth drivers, concentrated store locations make O'Reilly vulnerable to regional issues.
Citizens Financial (CFG) Raises Prime Rate, Cost Woes Linger
The Zacks analyst thinks ongoing efficiency initiatives and increase in prime lending rate are likely to bolster the company's growth profile.
Lam Research (LRCX) Memory, Foundry & Logic Segments Strong
The covering analyst believes that Lam's exposure to memory manufacturers and opportunity in logic and foundry segments are positives.
Aetna (AET) Continues to Grow, Merger Remains Uncertain
The Zacks analyst believes Aetna will grow on cost cutting efforts, strong Government biz and solid balance sheet.
Itau Unibanco (ITUB) Poised for Growth on Strategic Move
The covering analyst thinks inorganic growth remained a key strength at Itau Unibanco, as reflected by its recent acquisition of BMG Consignado.
Zoetis' (ZTS) Cost Reduction Initiatives to Drive Growth
The Zacks analyst believes that Zoetis' comprehensive operational efficiency initiatives will drive the company's margins and generate cost savings of over $300 million by 2017 end.
Eversource Energy's (ES) Investments Aid Customer Retention
Eversource Energy's systematic investments in infrastructure development projects, primarily in transmission and distribution systems, will help it to provide reliable services and retain customers.
BB&T (BBT) Poised for Growth, Raises Prime Lending Rate
The Zacks analyst remains encouraged by BB&T's strategic moves and rising loans and deposits that fuels its growth profile. Also, the recent hike in its prime lending rate will boost revenue growth.
Hanesbrands' (HBI) Activewear Soft; Brand Loses Share
The Zacks analyst thinks Hanesbrands faces headwinds like soft sales in Activewear segment and declining share of its Champion brand. The focus on premium items is detrimental to sales.
STERIS' (STE) Narrow '17 Outlook Signals Gloomy State Ahead
The covering analyst thinks STERIS may be hit by lowered revenue guidance for fiscal 2017. Also regulations to curb healthcare cost have been putting pressure on the stock.
Wyndham (WYN) Revenues Hit by Economic & Currency Woes
The Zacks analyst believes that revenue growth at Wyndham might be restricted because of the lingering political uncertainty in key international markets and significant currency headwinds.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ZOETIS INC (ZTS): Free Stock Analysis Report
WELLS FARGO-NEW (WFC): Free Stock Analysis Report
STERIS PLC (STE): Free Stock Analysis Report
DANAHER CORP (DHR): Free Stock Analysis Report
COLGATE PALMOLI (CL): Free Stock Analysis Report
AETNA INC-NEW (AET): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research